Catalog No.
PHC07301
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human OAT (Met1-Val301).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
Ornithine--oxo-acid aminotransferase,Ornithine delta-aminotransferase,Ornithine aminotransferase,mitochondrial,OAT
Purification
Purified by antigen affinity column.
Accession
P04181
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Food microstructure and protein digestion in the human gastrointestinal tract: an ileostomy study focusing on interindividual variability in gluten digestibility., PMID:40326566
Bioluminescence readout lateral flow immunoassay using nanobody targeting aflatoxin B1., PMID:40094173
Development of a direct competitive enzyme-linked immunosorbent assay (dc-ELISA) for the detection of scopolamine in wheat., PMID:39642284
Opioid agonist treatment programs and hepatitis C virus elimination in Taiwan: Ways of expanding the care cascade in screening and treatment., PMID:39541763
Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage., PMID:39341602
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate., PMID:39215044
In Vitro Metabolism and Transport Characteristics of Zastaprazan., PMID:38931920
First report of Triticum mosaic virus infecting oat crop in the United States., PMID:38840488
Exploring Gluten Assessment in Marketed Products through a Sandwich ELISA Methodology Based on Novel Recombinant Antibodies., PMID:38731712
Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional study., PMID:38579293
Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada., PMID:38385850
"Three-in-One" Multifunctional Hollow Nanocages with Colorimetric Photothermal Catalytic Activity for Enhancing Sensitivity in Biosensing., PMID:38364099
Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?, PMID:38218700
Oat β-D-glucan ameliorates type II diabetes through TLR4/PI3K/AKT mediated metabolic axis., PMID:37516222
IgG food hypersensitivity: A potential hidden precipitant for chronic spontaneous urticaria A case report., PMID:37422791
Double-Enzyme Active Vanadium Nanospheres-Mediated Ratiometric Multicolor Immunosensors for Sensitive Detection of the T-2 Toxin., PMID:36898021
Non-B-form DNA tends to form in centromeric regions and has undergone changes in polyploid oat subgenomes., PMID:36574697
HCV elimination in a Swiss opioid agonist therapy programme - a cohort study., PMID:36509421
Quantitative determination of four mycotoxins in cereal by fluorescent microsphere based immunochromatographic assay., PMID:36440754
Effects of Strategic Supplementation with Lupinus angustifolius and Avena sativa Grains on Colostrum Quality and Passive Immunological Transfer to Newborn Lambs., PMID:36428387
Characterization of high Arabinoxylan oat lines identified from a mutagenized oat population., PMID:36323030
Changes in the expression of drug-metabolising enzymes and drug transporters in mice with collagen antibody-induced arthritis., PMID:36278306
Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances., PMID:36183490
Daily Intake of a Phaseolus vulgaris L. Snack Bar Attenuates Hypertriglyceridemia and Improves Lipid Metabolism-Associated Plasma Proteins in Mexican Women: A Randomized Clinical Trial., PMID:35719139
Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records., PMID:35655277
Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020., PMID:35490624
Development of a Fluorescent Microfluidic Device Based on Antibody Microarray Read-Out for Therapeutic Drug Monitoring of Acenocoumarol., PMID:35425765
Specific Avenin Cross-Reactivity with G12 Antibody in a Wide Range of Current Oat Cultivars., PMID:35206043
Quantification of Barley Contaminants in Gluten-Free Oats by Four Gluten ELISA Kits., PMID:35156817
'Not just one box that you tick off' - Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective., PMID:35151085
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial., PMID:35101364
Inactivators of Ornithine Aminotransferase for the Treatment of Hepatocellular Carcinoma., PMID:35059122
High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study., PMID:35019254
Molecular super-gluing: a straightforward tool for antibody labelling and its application to mycotoxin biosensing., PMID:34978587
Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient-centered program from Italy., PMID:34697911
Investigation of Protein and Epitope Characteristics of Oats and Its Implications for Celiac Disease., PMID:34660657
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system., PMID:34607193
Evaluation of the discriminatory potential of antibodies created from synthetic peptides derived from wheat, barley, rye and oat gluten., PMID:34555094
A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment., PMID:34504786
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial., PMID:34444843
A Novel Sprouted Oat Fermented Beverage: Evaluation of Safety and Health Benefits for Celiac Individuals., PMID:34444682
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment., PMID:34241774
Food Safety and Cross-Contamination of Gluten-Free Products: A Narrative Review., PMID:34210037
A stable and sensitive enzyme-linked immunosorbent assay (ELISA) for the determination of metsulfuron-methyl residues in foods., PMID:34176121
Identification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker., PMID:34079468
Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium., PMID:34001145
An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran., PMID:33991887
Altered Profile of E1-S Transporters in Endometrial Cancer: Lower Protein Levels of ABCG2 and OSTβ and Up-Regulation of SLCO1B3 Expression., PMID:33917029
Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort., PMID:33705563
For research use only. Not for human or drug use.
